×
About 3,690 results

ALLMedicine™ Rosacea Center

Research & Reviews  886 results

A randomized, controlled, split-face study of topical timolol maleate 0.5% eye drops fo...
https://doi.org/10.1111/jocd.14347
Journal of Cosmetic Dermatology; Wei D, Hamblin MR et. al.

Aug 2nd, 2021 - Centrofacial erythema associated with telangiectasis is the most common presentation of rosacea, known as erythematotelangiectatic rosacea (ETR). However, successful management of these symptoms remains challenging. The purpose of this study was t...

β2-adrenoreceptors control human skin microvascular reactivity.
https://doi.org/10.1684/ejd.2021.4068
European Journal of Dermatology : EJD; Morell A, Milara J et. al.

Jul 27th, 2021 - Topical α1- and α2-adrenoreceptor (ADRA1 and 2) agonists are effective in alleviating permanent vasodilation and facial erythema associated with rosacea by inducing skin vasoconstriction. Although β-adrenoreceptor (ADRB) antagonists are used off-l...

Reproductive and hormonal factors and risk of incident rosacea among US White women.
https://doi.org/10.1016/j.jaad.2021.06.865
Journal of the American Academy of Dermatology; Wu WH, Geng H et. al.

Jul 19th, 2021 - Reproductive and hormonal factors and risk of incident rosacea among US White women.|2021|Wu WH,Geng H,Cho E,Eliassen AH,Drucker AM,|

A Novel Surgical Approach for Rhinophyma: Experience From a Cohort of Thirty Patients.
https://doi.org/10.1097/SCS.0000000000007963
The Journal of Craniofacial Surgery; Li W, He X et. al.

Jul 17th, 2021 - Rhinophyma is the severe rosacea whit hypertrophy of sebaceous glands in nasal tissue, which severely influences the patient's appearance. Surgical therapy is the best method for treating moderate-to-severe rhinophyma. In this study, we used a new...

Intense Pulsed Light: A Therapeutic Option for Patients With Rosacea-Related Dry Eye an...
https://doi.org/10.1097/WNO.0000000000001290
Journal of Neuro-ophthalmology : the Official Journal of ... Monterastelli AN, Bailey LA et. al.

Jul 17th, 2021 - Intense Pulsed Light: A Therapeutic Option for Patients With Rosacea-Related Dry Eye and Blepharospasm.|2021|Monterastelli AN,Bailey LA,Cockerham K,|

see more →

Guidelines  3 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Consensus recommendations from the American Acne & Rosacea Society on the management of...
https://www.ncbi.nlm.nih.gov/pubmed/24343208
Cutis Del Rosso JQ, Thiboutot D et. al.

Dec 18th, 2013 - Rosacea is a common clinical diagnosis that encompasses a variety of presentations, predominantly involving the centrofacial skin. Reported to present most commonly in adults of Northern European heritage with fair skin, rosacea can affect males a...

Evidence-based recommendations for the diagnosis and treatment of pediatric acne.
https://doi.org/10.1542/peds.2013-0490B
Pediatrics Eichenfield LF, Krakowski AC et. al.

May 3rd, 2013 - Acne vulgaris is one of the most common skin conditions in children and adolescents. The presentation, differential diagnosis, and association of acne with systemic pathology differs by age of presentation. Current acknowledged guidelines for the ...

see more →

Drugs  196 results see all →

Clinicaltrials.gov  79 results

A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules
https://clinicaltrials.gov/ct2/show/NCT03340961

Apr 21st, 2020 - Two hundred (200) male and female subjects with papulopustular rosacea will be enrolled to get 176 completed subjects (forty-four (44) completers each in groups 1 to 4). After assessing eligibility during an up to 28 days screening period, 200 sub...

Lipidome and Microbiome Profile of the Eye in Rosacea
https://clinicaltrials.gov/ct2/show/NCT03655197

Apr 7th, 2020 - Rosacea is a common condition that has multiple subtypes that exhibit inflammation and deficits in the skin/eye barrier function. Cutaneous rosacea is estimated to have an incidence of 10-22% while the prevalence of ocular rosacea ranging from 6-7...

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
https://clinicaltrials.gov/ct2/show/NCT00417937

Apr 1st, 2020 - To test the efficacy and safety of once vs twice daily application of azelaic acid 15% gel on papulopustular rosacea

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
https://clinicaltrials.gov/ct2/show/NCT01257919

Apr 1st, 2020 - Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel. Assessment of safety after repeated skin application.

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea
https://clinicaltrials.gov/ct2/show/NCT03276936

Feb 11th, 2020 - This is an open-label, multicenter, 40-week extension study to evaluate the long-term safety, tolerability, and efficacy of FMX103 1.5% topical foam in the treatment of moderate-to-severe facial papulopustular rosacea. Subjects entering this study...

see more →

News  300 results

Review Finds Diverse Outcomes in Clinical Trials of Rosacea
https://www.medscape.com/viewarticle/952022

May 27th, 2021 - There is an unmet need to standardize outcomes that are reported in clinical trials of rosacea, according to the authors of a new systematic review of rosacea treatment studies. "Rosacea is a chronic dermatologic condition that affects 16 million ...

Inflammatory Skin Diseases and CKD Risk: What’s the Link?
https://www.medscape.com/viewarticle/947916

Mar 23rd, 2021 - Takeaway Atopic eczema, psoriasis and hidradenitis suppurativa were weakly associated with chronic kidney disease (CKD), independent of obesity, cardiovascular morbidity or non-biologic nephrotoxic skin medications. No evidence supporting this ass...

Vasodilatory Medications Found Protective Against Rosacea
https://www.medscape.com/viewarticle/947490

Mar 15th, 2021 - Vasodilators may have a protective effect against rosacea, results from a single-center retrospective cohort study showed. "Our initial hypothesis was that perhaps antihypertensive agents might be associated with worsening rosacea," one of the stu...

Energy-Based Devices: Expert Shares Treatment Tips for Rosacea, Scars
https://www.medscape.com/viewarticle/947030

Mar 8th, 2021 - When treating rosacea/telangiectasia with energy-based devices, the 595-nm pulsed dye laser (PDL) or the 532-nm potassium titanyl phosphate (KTP) laser are the first line options, according to a 2020 international consensus publication that Jeremy...

A 26-Year-Old With Chronic Eye Pain: Osmosis USMLE Study Question
https://www.medscape.com/viewarticle/853100

Jan 22nd, 2021 - Test yourself with this question from Osmosis.org and see how you stack up against your peers! A 26-year-old woman is evaluated for chronic eye pain and eye redness. She also reports some photophobia and says that her pain is not significantly cha...

see more →

Patient Education  12 results see all →